Variant report
Variant | nsv599127 |
---|---|
Chromosome Location | chr5:98826218-98841199 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:29)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:29 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:98836275-98836477 | HepG2 | liver: | n/a | chr5:98836412-98836423 chr5:98836442-98836453 |
2 | CTCF | chr5:98826644-98826677 | GM13976 | blood: | n/a | n/a |
3 | CTCF | chr5:98831941-98832025 | Fibrobl | skin: | n/a | n/a |
4 | MAFF | chr5:98826125-98826395 | HepG2 | liver: | n/a | n/a |
5 | MAFK | chr5:98826165-98826368 | IMR90 | lung: | n/a | chr5:98826235-98826252 |
6 | MAFK | chr5:98826125-98826399 | HepG2 | liver: | n/a | chr5:98826235-98826252 |
7 | MAFK | chr5:98826111-98826416 | HepG2 | liver: | n/a | chr5:98826235-98826252 |
8 | MAFK | chr5:98826204-98826303 | K562 | blood: | n/a | chr5:98826235-98826252 |
9 | MYC | chr5:98828373-98828436 | MCF-7 | breast: | n/a | n/a |
10 | MYC | chr5:98828321-98828439 | MCF-7 | breast: | n/a | n/a |
11 | MYC | chr5:98828368-98828475 | MCF-7 | breast: | n/a | n/a |
12 | POLR2A | chr5:98828979-98829062 | ProgFib | skin: | n/a | n/a |
13 | POLR2A | chr5:98829244-98829253 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | POLR2A | chr5:98831912-98832040 | MCF-7 | breast: | n/a | n/a |
15 | POLR2A | chr5:98828293-98828479 | MCF-7 | breast: | n/a | n/a |
16 | POLR2A | chr5:98831952-98831968 | MCF-7 | breast: | n/a | n/a |
17 | POLR2A | chr5:98831976-98832000 | MCF-7 | breast: | n/a | n/a |
18 | POLR2A | chr5:98828364-98828486 | Gliobla | brain: | n/a | n/a |
19 | POLR2A | chr5:98831695-98831830 | ProgFib | skin: | n/a | n/a |
20 | POLR2A | chr5:98832008-98832024 | MCF-7 | breast: | n/a | n/a |
21 | POLR2A | chr5:98828270-98828457 | MCF-7 | breast: | n/a | n/a |
22 | POLR2A | chr5:98828318-98828469 | ProgFib | skin: | n/a | n/a |
23 | POLR2A | chr5:98828457-98828476 | A549 | lung: | n/a | n/a |
24 | POLR2A | chr5:98828382-98828449 | A549 | lung: | n/a | n/a |
25 | POLR2A | chr5:98831967-98831974 | Gliobla | brain: | n/a | n/a |
26 | SPI1 | chr5:98837393-98837595 | GM12878 | blood: | n/a | n/a |
27 | SPI1 | chr5:98837383-98837588 | GM12891 | blood: | n/a | n/a |
28 | SPI1 | chr5:98837463-98837593 | GM12878 | blood: | n/a | n/a |
29 | SPI1 | chr5:98837463-98837635 | GM12891 | blood: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RGMB-8 | chr5:98834774-98835071 | NONHSAT102979 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000249444 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572040477 | chr5:98829407-98829408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534454496 | chr5:98829437-98829438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs59925898 | chr5:98829475-98829476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138198845 | chr5:98829494-98829495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190416513 | chr5:98829527-98829528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181688393 | chr5:98829543-98829544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531090729 | chr5:98829548-98829549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6868003 | chr5:98829592-98829593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148325633 | chr5:98829610-98829611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370076496 | chr5:98829674-98829675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73776521 | chr5:98829675-98829676 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs543549067 | chr5:98829727-98829728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553383182 | chr5:98829768-98829769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566014468 | chr5:98829784-98829785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs539343650 | chr5:98829851-98829852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112691276 | chr5:98829873-98829874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564920923 | chr5:98829883-98829884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576167169 | chr5:98829888-98829889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532355148 | chr5:98829894-98829895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543569350 | chr5:98829896-98829897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs60874116 | chr5:98829930-98829931 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs559705012 | chr5:98829941-98829942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186810104 | chr5:98829967-98829968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540657961 | chr5:98829974-98829975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558911888 | chr5:98829979-98829980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6871348 | chr5:98829988-98829989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs6893582 | chr5:98830018-98830019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190899374 | chr5:98830041-98830042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6871375 | chr5:98830044-98830045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs6893602 | chr5:98830051-98830052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6871399 | chr5:98830083-98830084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563969285 | chr5:98830091-98830092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs6893760 | chr5:98830146-98830147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375183022 | chr5:98830156-98830157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185137060 | chr5:98830190-98830191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs55873846 | chr5:98830195-98830196 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs528581884 | chr5:98830209-98830210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570080766 | chr5:98830216-98830217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs547057260 | chr5:98830217-98830218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs375920241 | chr5:98830269-98830270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571665731 | chr5:98830355-98830356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113577021 | chr5:98830364-98830365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551400882 | chr5:98830375-98830376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs71618678 | chr5:98830378-98830379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554263209 | chr5:98831730-98831731 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs576027098 | chr5:98831748-98831749 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs543108708 | chr5:98831917-98831918 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs376531573 | chr5:98831924-98831925 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs149375560 | chr5:98831944-98831945 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs577083573 | chr5:98831978-98831979 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:98829400-98830400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr5:98830000-98830400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr5:98830000-98830400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |